Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Thomas Oxley | M | - |
Synchron, Inc.
 Synchron, Inc. Packaged SoftwareTechnology Services Synchron, Inc. operates as a medical device company that develops neural interface technology. It offers Stentrode, an endovascular electrode array. The company was founded by Thomas Oxley and Nicholas Opie and is headquartered in Campbell, CA.
SmartStent Pty Ltd.
 SmartStent Pty Ltd. Computer Processing HardwareElectronic Technology SmartStent Pty Ltd. develops medical technology for vascular bionics. The firm offers STENTRODE, a stent-based electrode array that is implanted by cerebral angiography. This minimally invasive day procedure will allow access to areas of the brain that control the movement of limbs, without having to perform open brain surgery. The company was founded by Thomas Oxley on November 30, 2012 and is headquartered in Melbourne, Australia. | 12 years |
| Rahul Sharma | M | - |
SmartStent Pty Ltd.
SmartStent Pty Ltd. Computer Processing HardwareElectronic Technology SmartStent Pty Ltd. develops medical technology for vascular bionics. The firm offers STENTRODE, a stent-based electrode array that is implanted by cerebral angiography. This minimally invasive day procedure will allow access to areas of the brain that control the movement of limbs, without having to perform open brain surgery. The company was founded by Thomas Oxley on November 30, 2012 and is headquartered in Melbourne, Australia.
Synchron, Inc.
Synchron, Inc. Packaged SoftwareTechnology Services Synchron, Inc. operates as a medical device company that develops neural interface technology. It offers Stentrode, an endovascular electrode array. The company was founded by Thomas Oxley and Nicholas Opie and is headquartered in Campbell, CA. | - |
| Martin S. Dieck | M | - |
SmartStent Pty Ltd.
SmartStent Pty Ltd. Computer Processing HardwareElectronic Technology SmartStent Pty Ltd. develops medical technology for vascular bionics. The firm offers STENTRODE, a stent-based electrode array that is implanted by cerebral angiography. This minimally invasive day procedure will allow access to areas of the brain that control the movement of limbs, without having to perform open brain surgery. The company was founded by Thomas Oxley on November 30, 2012 and is headquartered in Melbourne, Australia.
Synchron, Inc.
Synchron, Inc. Packaged SoftwareTechnology Services Synchron, Inc. operates as a medical device company that develops neural interface technology. It offers Stentrode, an endovascular electrode array. The company was founded by Thomas Oxley and Nicholas Opie and is headquartered in Campbell, CA. | - |
| Amos Meltzer | M | 58 |
Synchron, Inc.
Synchron, Inc. Packaged SoftwareTechnology Services Synchron, Inc. operates as a medical device company that develops neural interface technology. It offers Stentrode, an endovascular electrode array. The company was founded by Thomas Oxley and Nicholas Opie and is headquartered in Campbell, CA. | - |
| Alex Morgan | M | - |
Synchron, Inc.
Synchron, Inc. Packaged SoftwareTechnology Services Synchron, Inc. operates as a medical device company that develops neural interface technology. It offers Stentrode, an endovascular electrode array. The company was founded by Thomas Oxley and Nicholas Opie and is headquartered in Campbell, CA. | - |
| Kimberly Ha | F | - |
Synchron, Inc.
Synchron, Inc. Packaged SoftwareTechnology Services Synchron, Inc. operates as a medical device company that develops neural interface technology. It offers Stentrode, an endovascular electrode array. The company was founded by Thomas Oxley and Nicholas Opie and is headquartered in Campbell, CA. | 3 years |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 6 | 100.00% |
| Australia | 3 | 50.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Nicholas Opie
- Personal Network
